人体基因编辑的法律规制——从《中华人民共和国民法典》第一千零九条出发  

Legal Regulation of Human Gene Editing:Starting with Article 1009 of Civil Code of the People's republic of China

作　　者：石佳友[1] 刘欢[2] SHI Jiayou;LIU Huan

机构地区：[1]教育部人文社会科学重点研究基地中国人民大学民商事法律科学研究中心 [2]中国人民大学法学院

出　　处：《西北工业大学学报（社会科学版）》2020年第4期90-98,共9页Journal of Northwestern Polytechnical University(Social Sciences)

基　　金：司法部国家法治与法学理论研究项目“人类胚胎基因编辑立法研究”(19SFB2035)。

摘　　要：人体基因编辑技术的发展在给人类社会带来福祉的同时,也蕴含着潜在的技术风险和社会风险。我国公法就此问题的规制既存在规范上的漏洞,且由于其规范功能难以单独实现规制目标,在治理体系和治理能力现代化背景下,人体基因编辑的法律规制须借助于公私法之间的沟通与协作实现一体化规制。《中华人民共和国民法典》第一百五十三条第1款、第一千零八条和第一千零九条作为转介规范,可将公法规范中有关人体基因编辑规制的价值判断和规制目标融入私法体系之中,促成两者在价值上的融贯,较为妥善地调和了两者之间的规制目标,从而实现人体基因编辑领域的公私法协同和规制现代化。The development of human gene editing technology not only brings benefits to human society,but also contains potential technical and social risks.There are some regulatory loopholes in the public law on this issue,and restricted by its normative functions,it is difficult to achieve its regulatory goal alone.In the background of governance system and capacity modernization,the legal regulation of human gene editing should be finalized by integrating public and private laws.Article 153(1),1008 and 1009 of Civil Code of the People's Republic of China,as the referral norms,can integrate the value judgment and regulation objectives of human gene editing regulation in public law into the private law system,promote the value integration of the two systems,and reconcile their regulatory objectives,so as to realize the synergy of public and private laws and the modernization of regulation in the field of human gene editing.

关 键 词：人体基因编辑 公法规制 私法规制 协同规制 治理现代化 

分 类 号：D923[政治法律—民商法学]